Search results
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 10 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very...
Benzinga via Yahoo Finance· 3 days agoEuropean pharma giant AstraZeneca Plc’s (NASDAQ:AZN) Covid vaccine, developed with the University of...
Supreme Court rejected military chaplains' lawsuit saying their careers were ruined after refusing...
Business Insider· 1 day agoThe Supreme Court denied military chaplains' lawsuit claiming retaliation for refusing the COVID-19 ...
MRNA vaccine effective in treating glioblastoma brain cancer in small trial
UPI· 9 hours agoThe cancer vaccine is based on mRNA technology similar to that used in COVID-19 vaccines, but in...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 4 hours agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called ...
COVID Rash: Explaining Short- and Long-Term Symptoms
Verywell Health via Yahoo News· 2 days agoA COVID-19 infection is treated by managing symptoms like fever and cough, but no cure exists for the virus. Likewise, rashes caused by...weakened immune...
Anti-vaccine website falsely claims Covid jabs behind cancer uptick
AFP via Yahoo News· 3 days agoStudies show that Covid-19 shots save lives, but anti-vaccine advocates claim they have caused a...
AstraZeneca admits in court documents that COVID-19 vaccine could cause serious rare side effect
Just the News· 1 day agoBritish pharmaceutical company AstraZeneca admitted in court documents for the first time that its ...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 6 hours agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Why Moderna Stock Blasted 13% Higher Today
Motley Fool via Yahoo Finance· 3 hours agoModerna (NASDAQ: MRNA) was a fine stock to heal an ailing portfolio on the second-to-last trading day of the week. The company, which developed and sells...